JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
VTGN Stock Price & Analysis - Vistagen Therapeutics | Ledgeburg
VTGN - Vistagen Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary VTGN Stock
Financials
Financials VTGN Stock
Loading...
Loading...
Home
Stocks
Vistagen Therapeutics, Inc. (VTGN)
Stock Overview
Annual
Quarterly
Revenue $USD
0
500K
1M
FY2016
FY2017
FY2018
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue $USD
0
100K
200K
300K
400K
500K
Q1 FY24
Q2 FY24
Q3 FY24
Q4 FY24
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Q2 FY26
Q3 FY26
Q4 FY26
Company Profile
No description available
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Employees
N/A
Founded
N/A
Company Website
N/A
Investor Relations
N/A
CEO
N/A
Headquarters
SOUTH SAN FRANCISCO, CA